Cited by 710Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

Evolution of the neuropathology of Alzheimer's disease

Braak, H., Braak, E.·1996·Acta Neurologica Scandinavica

DOI 10.1111/j.1600-0404.1996.tb05866.x

Open this paper in CoChat — free account

Abstract

Our knowledge of the etiology and pathogenesis of Alzheimer's disease is limited. The most conspicuous changes seen in the brain are deposits of insoluble proteins in both extracellular and intraneuronal locations. The extracellular deposits consist primarily of a specific A4 amyloid protein. The significance of these deposits remains to be determined, as they are often found in the cerebral cortex of non-demented elderly persons. More telling is the gradual accumulation of insoluble fibrous material within some neurons that consists mainly of abnormally phosphorylated tau protein. Six stages of increasingly severe cortical destruction can be distinguished. Stages I and II are characterized by neurofibrillary changes that are largely confined to the transentorhinal region, whereas stages III and IV are marked by severe involvement of both the entorhinal and transentorhinal regions. Isocortical destruction occurs during stages V and VI. This progression in cortical pathology correlates with the gradual worsening of clinical symptoms.

Integrity signals

Registry

Crossref · 10.1111/j.1600-0404.1996.tb05866.x

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Self-citation
Distributed hierarchical processing in the primate cerebral cortex
Felleman, D. J., & Van Essen, D. C. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.1 · Cited by 7,783
Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans.
Squire, L. R. (1992) · Psychological Review · doi:10.1037/0033-295x.99.2.195 · Cited by 5,376
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Preface: Cerebral Cortex Has Come of Age
Goldman, P. S., & RAKIC, P. T. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.1-a · Cited by 3,537
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Staging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Self-citation
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
Functional Assessment Staging (FAST)
Gauthier, S. G. (2001) · CRC Press eBooks · doi:10.3109/9780203213896-33 · Cited by 1,023

Show all 53 references

Research works printed but not linked: 2

Kemper, 1978, Senile dementia: a biomedical approach, 105
Braak, 1993, Alzheimer's disease: advances in clinical and basic research. Third International Conference on Alzheimer's Disease and Related Disorders, 131

Sorted by citations

Items 401–500 of 710

Electrophysiological evidence of altered facial expressions recognition in Alzheimer’s disease: A comprehensive ERP study
Fide, E., Emek‐Savaş, D. D., Aktürk, T., Güntekin, B., Hanoğlu, L., & Yener, G. (2019) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.06.229 · Cited by 21
Loneliness is linked to specific subregional alterations in hippocampus-default network covariation
Zajner, C., Spreng, R. N., & Bzdok, D. (2021) · Journal of Neurophysiology · doi:10.1152/jn.00339.2021 · Cited by 18
Episodic memory of APOE ε4 carriers is correlated with fractional anisotropy, but not cortical thickness, in the medial temporal lobe
Westlye, E. T., Hodneland, E., Haász, J., Espeseth, T., Lundervold, A., & Lundervold, A. J. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.06.072 · Cited by 20
THE ROLE OF THE SEPTOHIPPOCAMPAL CHOLINERGIC SYSTEM IN COGNITIVE FUNCTIONS
Yliopisto, K., & Ikonen, S. (2001) · Cited by 19
Understanding the complex interplay between tau, amyloid and the network in the spatiotemporal progression of Alzheimer’s disease
Raj, A., Torok, J., & Ranasinghe, K. G. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102750 · Cited by 20
Frontotemporal dementia and dementia with Lewy bodies in a case-control study of Alzheimer's disease
Piguet, O., Halliday, G. M., Creasey, H. M., Broe, G. A., & Kril, J. J. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209009454 · Cited by 18
Hippocampal subfield surface deformity in nonsemantic primary progressive aphasia
Christensen, A., Alpert, K. I., Rogalski, E. J., Cobia, D. J., Rao, J. A., Beg, M. F., Weıntraub, S., Mesulam, M. M., & Wang, L. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2014.11.013 · Cited by 18
Alzheimer β-amyloid blocks epileptiform activity in hippocampal neurons
Sepúlveda, F. J., Opazo, C., & Aguayo, L. G. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.04.012 · Cited by 18
A predominance of category deficits for living things in Alzheimer's disease and Lewy body dementia
Laws, K. R., Crawford, J. R., Gnoato, F., & Sartori, G. (2007) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617707070610 · Cited by 18
The Hippocampal Subfield Volume Reduction and Plasma Biomarker Changes in Mild Cognitive Impairment and Alzheimer’s Disease
Cao, J., Tang, Y., Chen, S., Yu, S., Wan, K., Yin, W., Zhen, W., Zhao, W., Zhou, X., Zhu, X., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231114 · Cited by 17
Haptoglobin 1-1 Genotype Modulates the Association of Glycemic Control With Hippocampal Volume in Elderly Individuals With Type 2 Diabetes
Livny, A., Ravona‐Springer, R., Heymann, A. D., Priess, R., Kushnir, T., Tsarfaty, G., Rabinov, L., Moran, R., Tik, N., Moshier, E. L., et al. (2017) · Diabetes · doi:10.2337/db16-0987 · Cited by 17
New pathways in drug discovery for alzheimer’s disease
Siemers, E., Dean, R. A., Demattos, R. B., & May, P. C. (2006) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-996-0017-8 · Cited by 17
Transplanted embryonic entorhinal neurons make functional synapses in adult host hippocampus
Zhou, W., Raisman, G., & Zhou, C. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01539-4 · Cited by 17
Autopsy-confirmed Alzheimer's disease versus clinically diagnosed Alzheimer's disease in the Cache County Study on Memory and Aging: A comparison of quantitative MRI and neuropsychological findings
Fearing, M. A., Bigler, E. D., Norton, M. C., Tschanz, J. A. T., Hulette, C., Leslie, C., Welsh-Bohmer, K. A., & the Cache County Investigators (2007) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390600826579 · Cited by 17
Correlations between Z‐scores of VSRAD and regional cerebral blood flow of SPECT in patients with Alzheimer's disease and mild cognitive impairment
Li, X., Shimizu, S., Jibiki, I., Watanabe, K., & Kubota, T. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02076.x · Cited by 16
Microtubule-modulating Agents in the Fight Against Neurodegeneration: Will it ever Work?
Soliman, A., Bakota, L., & Brandt, R. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666211201101020 · Cited by 19
Barriers to Effective Memory Assessments for Alzheimer’s Disease
Parra, M. A. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215445 · Cited by 17
Correlation of Aβ deposition in the nasal cavity with the formation of senile plaques in the brain of a transgenic mouse model of Alzheimer's disease
Kameshima, N., Nanjo, T., Fukuhara, T., Yanagisawa, D., & Tooyama, I. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.02.026 · Cited by 16
Effects of Entorhinal Cortex Lesions on Sensory Integration and Spatial Learning
Davis, A. E., Gimenez, A. M., & Therrien, B. A. (2001) · Nursing Research · doi:10.1097/00006199-200103000-00003 · Cited by 16
Applause sign in Alzheimer’s disease: relationships to cognitive profile and severity of illness
Luzzi, S., Fabi, K., Pesallaccia, M., Silvestrini, M., & Provinciali, L. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6608-1 · Cited by 16
Relationship between cognitive impairment and behavioural disturbances in Alzheimer's disease patients.
Serra, L., Perri, R., Fadda, L., Padovani, A., Lorusso, S., Pettenati, C., Caltagirone, C., & Carlesimo, G. A. (2010) · Europe PMC (PubMed Central) · doi:10.3233/ben-2010-0275 · Cited by 16
Alzheimer's Disease
Noroozıan, M. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.08.005 · Cited by 18
Diagnosis of dementia – automatic quantification of brain structures
Engedal, K., Brækhus, A., Andreassen, O. A., & Nakstad, P. (2012) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.12.0148 · Cited by 17
Modelling pathological spread through the structural connectome in the frontotemporal dementia clinical spectrum
Agosta, F., Basaia, S., Spinelli, E. G., Facente, F., Lumaca, L., Ghirelli, A., Canu, E., Castelnovo, V., Sibilla, E., Tripodi, C., et al. (2024) · Brain · doi:10.1093/brain/awae391 · Cited by 15
Calcium signaling in individual APP/PS1 mouse dentate gyrus astrocytes increases ex vivo with Aβ pathology and age without affecting astrocyte network activity
Huffels, C. F. M., Osborn, L. M., Cappaert, N. L. M., & Hol, E. M. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25042 · Cited by 13
Novel repertoire of tau biosensors to monitor pathological tau transformation and seeding activity in living cells
Cecon, E., Oishi, A., Luka, M., Ndiaye‐Lobry, D., François, A., Lescuyer, M., Panayi, F., Dam, J., Machado, P., & Jockers, R. (2023) · eLife · doi:10.7554/elife.78360 · Cited by 17
Omentum transposition surgery for patients with Alzheimer's disease: a case series
Shankle, W. R., Hara, J., Bjornsen, L., Gade, G. F., Leport, P. C., Ali, M. B., Kim, J., Raimo, M., Reyes, L., Amen, D., et al. (2008) · Neurological Research · doi:10.1179/016164107x230126 · Cited by 15
Disentangling the Contribution of Spatial Reference Frames to Executive Functioning in Healthy and Pathological Aging: An Experimental Study with Virtual Reality
Serino, S., Morganti, F., Colombo, D., Pedroli, E., Cipresso, P., & Riva, G. (2018) · Sensors · doi:10.3390/s18061783 · Cited by 16
Macroscopic modelling of Alzheimer’s disease: difficulties and challenges
Bertsch, M., Franchi, B., Raj, A., & Tesi, M. C. (2021) · Brain Multiphysics · doi:10.1016/j.brain.2021.100040 · Cited by 14
Amalaki Rasayana improved memory and neuronal metabolic activity in AβPP-PS1 mouse model of Alzheimer’s disease
Tiwari, V., Saba, K., Veeraiah, P., Jose, J., Lakhotia, S. C., & Patel, A. B. (2017) · Journal of Biosciences · doi:10.1007/s12038-017-9692-7 · Cited by 15
Embryonic entorhinal transplants partially ameliorate the deficits in spatial memory in adult rats with entorhinal cortex lesions
Zhou, W., Jiang, D., Raisman, G., & Zhou, C. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00125-5 · Cited by 15
Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample
Luis, C. A., Barker, W., Gajaraj, K., Harwood, D. G., Petersen, R., Kashuba, A., Waters, C., Jimison, P., Pearl, G. S., Petito, C. K., et al. (1999) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199907)14:7 · Cited by 140
Path integration deficits are associated with phosphorylated tau accumulation in the entorhinal cortex
Koike, R., Soeda, Y., Kasai, A., Fujioka, Y., Ishigaki, S., Yamanaka, A., Takaichi, Y., CHAMBERS, J. K., Uchida, K., Watanabe, H., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad359 · Cited by 17
Activation of Neuronal Defense Mechanisms in Response to Pathogenic Factors Triggering Induction of Amyloidosis in Alzheimer's Disease
Maltsev, A. V., Santockyte, R., Bystryak, S. M., & Galzitskaya, O. V. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131562 · Cited by 16
Rck/p54 interacts with APP mRNA as part of a multi-protein complex and enhances APP mRNA and protein expression in neuronal cell lines
Broytman, O., Westmark, P. R., Gürel, Z., & Malter, J. S. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.011 · Cited by 14
Aging-Related Calcium Dysregulation in Rat Entorhinal Neurons Homologous with the Human Entorhinal Neurons in which Alzheimer’s Disease Neurofibrillary Tangles First Appear
Gant, J. C., Kadish, I., Chen, K.-C., Thibault, O., Blalock, E. M., Porter, N. M., & Landfield, P. W. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180618 · Cited by 14
Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: Effects of APP/PS1 genotype and ovariectomy
Miettinen, R. A., Riedel, A., Kalesnykas, G., Kettunen, H.-P., Puoliväli, J. T., Soininen, H. S., & Arendt, T. (2005) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2005.06.003 · Cited by 14
Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
Kayed, R., Castillo‐Carranza, D. L., & Guerrero‐Munoz, M. J. (2013) · ImmunoTargets and Therapy · doi:10.2147/itt.s40131 · Cited by 16
The “when” matters: Evidence from memory markers in the clinical continuum of Alzheimer’s disease.
Forno, G., Parra, M. A., Thumala, D., Villagra, R., Cerda, M., Pedro Zitko, M., Ibáñez, A. M., Lillo, P., & Slachevsky, A. (2023) · Neuropsychology · doi:10.1037/neu0000891 · Cited by 13
“Back to Braak”: Role of Nucleus Reuniens and Subcortical Pathways in Alzheimer's Disease Progression
Censi, S. T., Sestieri, C., Punzi, M., Pizzi, A. D., Ferretti, A., Gambi, F., Tomassini, V., Pizzi, S. D., & Sensi, S. L. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.42 · Cited by 14
Insights from the neural guidance factor Netrin-1 into neurodegeneration and other diseases
Cai, M., Zheng, Q., Chen, Y., Liu, S., Zhu, H., & Bai, B. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1379726 · Cited by 16
How the cognitive reserve interacts with β-amyloid deposition in mitigating FDG metabolism
Carapelle, E., Serra, L., Modoni, S., Falcone, M., Caltagirone, C., Bozzali, M., Specchio, L. M., & Avolio, C. (2017) · Medicine · doi:10.1097/md.0000000000005876 · Cited by 13
The Role of MRI Biomarkers and Their Interactions with Cognitive Status and APOE ε4 in Nondemented Elderly Subjects
Liang, X., Yin, Z., Liu, R., Zhao, H., Wu, S., Lu, J., Zhao, Q., Wei, Y., Yang, Q., Zhu, B., et al. (2018) · Neurodegenerative Diseases · doi:10.1159/000495754 · Cited by 12
Comparison of phosphorylated TDP-43-positive inclusions in oculomotor neurons in patients with non-ALS and ALS disorders
Mizuno, Y., Fujita, Y., Takatama, M., & Okamoto, K. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.12.012 · Cited by 13
Relationship between Cognitive Impairment and Behavioural Disturbances in Alzheimer’s Disease Patients
Serra, L., Perri, R., Fadda, L., Padovani, A., Lorusso, S., Pettenati, C., Caltagirone, C., & Carlesimo, G. A. (2010) · Behavioural Neurology · doi:10.1155/2010/528694 · Cited by 13
Semantic Fluency in Mild and Moderate Alzheimer's Disease
Pekkala, S. (2004) · Työväentutkimus Vuosikirja · Cited by 14
Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer's disease
Ohm, D. T., Fought, A. J., RADEMAKER, A. W., Kım, G., Sridhar, J., Coventry, C., Gefen, T. D., Weıntraub, S., Bigio, E. H., Mesulam, M. M., et al. (2019) · Brain Pathology · doi:10.1111/bpa.12783 · Cited by 14
Microtubule-modulating Agents in the Fight Against Neurodegeneration: Will it ever Work?
Soliman, A., Bakota, L., & Brandt, R. (2022) · UCL Discovery (University College London) · Cited by 12
Modified test statistics by inter-voxel variance shrinkage with an application to f MRI
Su, S.-C., Caffo, B. S., Garrett-Mayer, E. S., & Bassett, S. S. (2008) · Biostatistics · doi:10.1093/biostatistics/kxn028 · Cited by 12
Clinical Aspects of Alzheimer’s Disease
Kurz, A., & Lauter, H. (2001) · Springer eBooks · doi:10.1007/978-3-642-59519-6_70 · Cited by 12
Imaging Alzheimer’s disease
Small, S. A. (2003) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-003-0021-1 · Cited by 12
Intervención neuropsicológica y del lenguaje en la enfermedad de Alzheimer. Descripción de un caso clínico
Cullell, N., Bruna, O., & Puyuelo, M. (2006) · Revista de Logopedia Foniatría y Audiología · doi:10.1016/s0214-4603(06)70116-4 · Cited by 12
CNS Gene Therapy and a Nexus of Complexity: Systems and Biology at a Crossroads
Tyler, C. M., & Federoff, H. J. (2006) · Cell Transplantation · doi:10.3727/000000006783982007 · Cited by 12
Spatial–temporal patterns of brain disconnectome in Alzheimer 's disease
Liang, L., Zhou, P., Ye, C., Yang, Q., & Ma, T. (2023) · Human Brain Mapping · doi:10.1002/hbm.26344 · Cited by 9
Advancing Nanomaterial-Based Strategies for Alzheimer’s Disease: A Perspective
Zhou, H., Yin, X., Zhang, G., Yang, Z., & Zhou, R. (2025) · JACS Au · doi:10.1021/jacsau.5c00002 · Cited by 15
Evaluation of apparent diffusion coefficient mappings in amnestic mild cognitive impairment using an image analysis software brain search
Zhang, B., Zhang, J., Zhao, H., Zhang, X., Li, M., Qian, L., Wang, K., Tian, C., Guo, W., Cao, Q., et al. (2011) · Acta Radiologica · doi:10.1258/ar.2011.100430 · Cited by 11
Transmission of Tau Pathology Induced by Synthetic Preformed Tau Filaments
Reyes, J. F., Rey, N. L., & Angot, É. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0725-13.2013 · Cited by 11
Subtle executive deficits are associated with higher brain amyloid burden and lower cortical volume in subjective cognitive decline: the FACEHBI cohort
Pérez‐Cordón, A., Monté, G. C., Sanabria, Á., Rodríguez‐Gómez, O., Valero, S., Ruiz, C. A., Marquié, M., Espinosa, A., Ortega, G., Hernandez, I., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-74704-7 · Cited by 14
Adaptive responses to alloxan‐induced mild oxidative stress ameliorate certain tauopathy phenotypes
Yoshiike, Y., Yamashita, S., Mizoroki, T., Maeda, S., Murayama, M., Kimura, T., Sahara, N., Soeda, Y., & Takashima, A. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00756.x · Cited by 11
Monophosphoryl Lipid-A: A Promising Tool for Alzheimer’s Disease Toll
Rego, Â. R., Viana, S., Ribeiro, C., Rodrigues‐Santos, P., & Pereira, F. C. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151183 · Cited by 11
The Proactive Self in Space: How Egocentric and Allocentric Spatial Impairments Contribute to Anosognosia in Alzheimer’s Disease
Serino, S., & Riva, G. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160676 · Cited by 11
Structural characterization of monoclonal antibodies targeting C-terminal Ser404 region of phosphorylated tau protein
Chukwu, J. E., Congdon, E. E., Sigurdsson, E. M., & Kong, X. (2019) · mAbs · doi:10.1080/19420862.2019.1574530 · Cited by 12
Memory-provoked rCBF-SPECT as a diagnostic tool in Alzheimer’s disease?
Sundström, T., Elgh, E., Larsson, A., Näsman, B., Nyberg, L. H., & Riklund, K. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1874-0 · Cited by 11
Combining Brain Imaging with Microarray: Isolating Molecules Underlying the Physiologic Disorders of the Brain
Pierce, A., & Small, S. A. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000023601.50101.7f · Cited by 11
Association of [ 18 F]Flortaucipir–PET and Plasma p-Tau217 With Tau Neuropathology in Alzheimer Disease and Other Neurodegenerative Disorders
Vrillon, A., Spina, S., Mejía‐Perez, J. A., LaMore, T., Yballa, C., Soleimani‐Meigooni, D. N., Blazhenets, G., Boxer, A. L., Rojas, J. C., Lago, A. L., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000214576 · Cited by 14
A Histochemical Analysis of Neurofibrillary Tangles in Olfactory Epithelium, a Study Based on an Autopsy Case of Juvenile Alzheimer’s Disease
Shimizu, S., Tojima, I., Nakamura, K., Kouzaki, H., Kanesaka, T., Ogawa, N., Hashizume, Y., Akatsu, H., Hori, A., Tooyama, I., et al. (2022) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.22-00048 · Cited by 10
Pathology steered stratification network for subtype identification in Alzheimer's disease
Xu, E., Zhang, J., Li, J., Song, Q., Yang, D., Guorong Wu, A., & Chen, M. (2023) · Medical Physics · doi:10.1002/mp.16655 · Cited by 10
(18F)FDG-PET as a Biomarker for Early Alzheimer's Disease
Nobili, F., & Morbelli, S. (2010) · The Open Nuclear Medicine Journal · doi:10.2174/1876388x01002010046 · Cited by 13
iTRAQ-based Proteomic Analysis of APPSw,Ind Mice Provides Insights into the Early Changes in Alzheimer’s Disease
Li, N., Hu, P., Xu, T., Chen, H., Chen, X., Hu, J., Yang, X., Shi, L., Luo, J., & Xu, J. (2017) · Current Alzheimer Research · doi:10.2174/1567205014666170719165745 · Cited by 11
Performance on a 1-week delayed recall task is associated with medial temporal lobe structures in neurologically normal older adults
Saloner, R., Casaletto, K. B., Marx, G. A., Dutt, S., Bussche, A. B. V., You, M. Y., Fox, E. P., Stiver, J., & Kramer, J. H. (2017) · The Clinical Neuropsychologist · doi:10.1080/13854046.2017.1370134 · Cited by 14
Cerebral Atherosclerosis and Mild Alzheimer’s Disease
Rafael, H. (2003) · Stroke · doi:10.1161/01.str.0000083464.56904.e5 · Cited by 10
Accuracy of CT scan measurements of the medial temporal lobe in routine dementia diagnostics
Øksengaard, A. R., Haakonsen, M., Dullerud, R., Engedal, K., & Laake, K. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.823 · Cited by 10
The utility of olfactory function in distinguishing early-stage Alzheimer's disease from HIV-associated neurocognitive disorders
Sundermann, E. E., Fields, A., Saloner, R., Gouaux, B. D., Bharti, A., Murphy, C., & Moore, D. J. (2020) · AIDS · doi:10.1097/qad.0000000000002761 · Cited by 11
Impairment of nonverbal recognition in Alzheimer disease
Anderson, K. E., Brickman, A., Flynn, J., Scarmeas, N., Heertum, R. V. V., Sackeim, H., Marder, K., Bell, K. F. S., Moeller, J. R., & Stern, Y. (2007) · Neurology · doi:10.1212/01.wnl.0000266561.47619.23 · Cited by 8
Associations between Recall of Proper Names in Story Recall and CSF Amyloid and Tau in a Cognitively Unimpaired Sample
Hale, M. R., Langhough, R. E., Du, L., Hermann, B. P., Hulle, C. A. V., Carboni, M., Kollmorgen, G., Basche, K. E., Bruno, D., Sanson‐Miles, L., et al. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.09.018 · Cited by 9
miR-519a-3p, found to regulate cellular prion protein during Alzheimer's disease pathogenesis, as a biomarker of asymptomatic stages
Jácome, D., Cotrufo, T., Andrés‐Benito, P., Lidón, L., Martı́, E., Ferrer, I., del Rı́o, J. A., & Gavı́n, R. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167187 · Cited by 10
High-affinity antibodies specific to the core region of the tau protein exhibit diagnostic and therapeutic potential for Alzheimer’s disease
Arastoo, M., Penny, L. K., Lofthouse, R. A., Abdallah, A., Abrahamsson, A., Marini, P., Melis, V., Riedel, G., Harrington, C. R., Wischik, C. M., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01561-1 · Cited by 9
Five-factor structure of the RBANS is supported in an Alzheimer’s disease sample: Implications for validation of neuropsychological assessment instruments
Holden, H. M., Milano, N. J., & Horner, M. D. (2018) · Applied Neuropsychology Adult · doi:10.1080/23279095.2018.1529671 · Cited by 9
Cerebral atrophy in elderly with subjective memory complaints
Palm, W. M., Ferrarini, L., van der Flier, W. M., Westendorp, R. G. J., Bollen, E. L. E. M., Middelkoop, H. A. M., Milles, J., van der Grond, J., & van Buchem, M. A. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23977 · Cited by 9
Alteration of perivascular spaces in early cognitive decline
Sepehrband, F., Barisano, G., Sheikh‐Bahaei, N., Choupan, J., Cabeen, R. P., Crawford, M. S., Mack, W. J., Chui, H. C., Ringman, J. M., Toga, A. W., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.045605 · Cited by 9
Memory Assessment in the Clinical Context Using Functional Magnetic Resonance Imaging
McAndrews, M. P. (2014) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2014.07.008 · Cited by 9
Imaging‐Guided Microarray
Pereira, A. C., Wu, W. E., & Small, S. A. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1379.005 · Cited by 9
Comparative Study of Injected Alzheimer’s Disease Models in Rats: Insights from Experimental Research
Doumar, H., Mostafi, H. E., Elhessni, A., Abderrahim, L., & Mesfioui, A. (2024) · Pathophysiology · doi:10.3390/pathophysiology31040047 · Cited by 8
Calpain Interactions with the Protein Phosphatase Calcineurin in Neurodegeneration
Norris, C. M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9099-9_2 · Cited by 8
Older, non-demented apolipoprotein ε4 carrier males show hyperactivation and structural differences in odor memory regions: a blood-oxygen-level-dependent and structural magnetic resonance imaging study
Kapoulea, E. A., & Murphy, C. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.04.013 · Cited by 8
On the reproducibility of hippocampal MEGA-sLASER GABA MRS at 7T using an optimized analysis pipeline
Völzke, Y., Pracht, E., Hattingen, E., Tse, D. H. Y., & Stöcker, T. (2020) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-020-00879-9 · Cited by 8
Acquisition and consolidation of verbal learning and episodic memory as predictors of the conversion from mild cognitive impairment to probable Alzheimer’s disease
López-Pérez, J., García‐Herranz, S., & Mardomingo, C. D. (2022) · Aging Neuropsychology and Cognition · doi:10.1080/13825585.2022.2069670 · Cited by 9
Decreased Cognitive Function in Extended Family Members from the Single Late-Onset-Alzheimer's-Disease Pedigree
Zeng, Y., Chang, W., Shu, C., Ma, L., Huang, Y., Wang, R., Zhang, J., Zhu, C., & McClintock, S. M. (2013) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617713000581 · Cited by 9
Caloric restriction mimetic 2-deoxyglucose maintains cytoarchitecture and reduces tau phosphorylation in primary culture of mouse hippocampal pyramidal neurons
Bele, M. S., Gajare, K. A., & Deshmukh, A. A. (2015) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-015-9867-1 · Cited by 9
β-Amyloid peptide (1–40) in the brain reaches the nasal cavity via a non-blood pathway
Kameshima, N., Yanagisawa, D., & Tooyama, I. (2013) · Neuroscience Research · doi:10.1016/j.neures.2013.03.016 · Cited by 8
Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits
Koss, D. J., Robinson, L., Mietelska‐Porowska, A., Gąsiorowska, A., Sepčić, K., Turk, T., Jaspars, M., Niewiadomska, G., Scott, R. H., Platt, B., et al. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1949-4 · Cited by 8
Evolution of β-amyloid induced neuropathology: magnetic resonance imaging and anatomical comparisons in the rodent hippocampus
Bhagat, Y. A., Obenaus, A., Richardson, J. S., & Kendall, E. J. (2002) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/bf02668216 · Cited by 8
Proteases and Alzheimer’s Disease: Present Knowledge and Emerging Concepts of Therapy
Bernstein, H. (2006) · Springer eBooks · doi:10.1007/0-387-23101-3_1 · Cited by 8
Aux frontières de l’Alzheimer
Chételat, G., Desgranges, B., Sayette, V. D. L., Viader, F., & Eustache, F. (2004) · Revue Neurologique · doi:10.1016/s0035-3787(04)70944-3 · Cited by 8
Comparative efficacy of intermittent theta burst stimulation and high-frequency repetitive transcranial magnetic stimulation in amnestic mild cognitive impairment patients
Zheng, W., Shi, X., Ya, C., Hou, X., Yang, Z., Yao, W., Lv, T., & Bai, F. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae460 · Cited by 9
Synaptic density patterns in early Alzheimer’s disease assessed by independent component analysis
Fang, X. T., Raval, N. R., O’Dell, R. S., Naganawa, M., Mecca, A. P., Chen, M.-K., van Dyck, C. H., & Carson, R. E. (2024) · Brain Communications · doi:10.1093/braincomms/fcae107 · Cited by 7
Neuroglia in neurodegeneration: Alzheimer, Parkinson, and Huntington disease
Lim, D., Matute, C., Cavaliere, F., & Verkhratsky, A. (2025) · Handbook of Clinical Neurology · doi:10.1016/b978-0-443-19102-2.00012-0 · Cited by 8
Alternative neural circuitry that might be impaired in the development of Alzheimer disease
Ávila, J., Perry, G. L., Strange, B. A., & Hernández, F. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00145 · Cited by 7
Neuronal Expression of Truncated Tau Efficiently Promotes Neurodegeneration in Animal Models: Pitfalls of Toxic Oligomer Analysis
Škrabana, R., Kováčech, B., Filipčík, P., Žilka, N., Jadhav, S., Smolek, T., Kontseková, E., & Novák, M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161124 · Cited by 7
Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European‐DLB consortium project
Bauckneht, M., Chincarini, A., Brendel, M., Rominger, A., Beyer, L., Bruffaerts, R., Vandenberghe, R. R., Kramberger, M. G., Trošt, M., Garibotto, V., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12294 · Cited by 7

Authors: Braak, H., & Braak, E.
Affiliations: Goethe University Frankfurt (DE)
Corresponding author: Braak, H.
ORCID: Braak, H.
Venue: Acta Neurologica Scandinavica
Publisher: Wiley
Published: 1996-04
Volume: 94
Issue: S165
Pages: 3-12
ISSN: 0001-6314 (ISSN-L)
DOI: 10.1111/j.1600-0404.1996.tb05866.x
OpenAlex: W1971744915
Cited by: 710
References: 53
Citations by year: 2026: 13 · 2025: 24 · 2024: 27 · 2023: 22 · 2022: 29 · 2021: 22 · 2020: 29 · 2019: 27 · 2018: 29 · 2017: 25 · 2016: 31 · 2015: 36 · 2014: 36 · 2013: 31 · 2012: 36
FWCI: 2.02
Type: journal article
Language: en
Open access: closed
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 7092 d)
Locations: Acta Neurologica Scandinavica (publishedVersion)
PubMed (publishedVersion)
Funders: Deutsche Forschungsgemeinschaft
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Alzheimer's disease, neuropathology, amyloid plaques, tau protein, neurofibrillary tangles, entorhinal cortex, cortical atrophy, disease stage, etiopathogenesis
MeSH terms: Alzheimer Disease, Hippocampus, Humans, Neurofibrillary Tangles, Entorhinal Cortex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Evolution of the neuropathology of Alzheimer's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks